Abstract
Anthracyclines are effective in the treatment of leukemia, but their use is limited because of cardiotoxicity. Liposomal daunorubicin (L-DNR) is potentially less cardiotoxic than daunorubicin (DNR). We compared in vitro cytotoxicity in pediatric acute leukemia samples and found no significant differences between cytotoxicity of DNR and L-DNR.
| Original language | English |
|---|---|
| Pages (from-to) | 1573-1574 |
| Number of pages | 2 |
| Journal | Haematologica |
| Volume | 91 |
| Issue number | 11 |
| Publication status | Published - Nov 2006 |
| Externally published | Yes |
Keywords
- Cardiotoxicity
- Drug sensitivity
- Liposomal daunombicin
- Pediatric acute leukemia